These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17005679)

  • 1. Human T-cell responses to vaccinia virus envelope proteins.
    Tang J; Murtadha M; Schnell M; Eisenlohr LC; Hooper J; Flomenberg P
    J Virol; 2006 Oct; 80(20):10010-20. PubMed ID: 17005679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.
    Clark KM; Johnson JB; Kock ND; Mizel SB; Parks GD
    Virology; 2011 Oct; 419(2):97-106. PubMed ID: 21885079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge.
    Pulford DJ; Gates A; Bridge SH; Robinson JH; Ulaeto D
    Vaccine; 2004 Sep; 22(25-26):3358-66. PubMed ID: 15308360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro human CD4+ T cell response to the vaccinia protective antigens B5R and A33R.
    Sirven P; Castelli FA; Probst A; Szely N; Maillere B
    Mol Immunol; 2009 Apr; 46(7):1481-7. PubMed ID: 19193441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell responses to respiratory syncytial virus fusion and attachment proteins in human peripheral blood mononuclear cells.
    de Waal L; Süzer Y; Wyatt LS; Sintnicolaas K; Sutter G; Moss B; Osterhaus AD; de Swart RL
    Viral Immunol; 2006; 19(4):669-78. PubMed ID: 17201662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization.
    Fang M; Remakus S; Roscoe F; Ma X; Sigal LJ
    J Virol; 2015 Jan; 89(1):776-83. PubMed ID: 25355885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox.
    Kaever T; Matho MH; Meng X; Crickard L; Schlossman A; Xiang Y; Crotty S; Peters B; Zajonc DM
    J Virol; 2016 May; 90(9):4334-4345. PubMed ID: 26889021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.
    Terajima M; Orphin L; Leporati AM; Pazoles P; Cruz J; Rothman AL; Ennis FA
    Hum Immunol; 2008 Dec; 69(12):815-25. PubMed ID: 18955096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of protective T-cell antigens for smallpox vaccines.
    Ando J; Ngo MC; Ando M; Leen A; Rooney CM
    Cytotherapy; 2020 Nov; 22(11):642-652. PubMed ID: 32747299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses to vaccinia membrane proteins after smallpox vaccination.
    Lawrence SJ; Lottenbach KR; Newman FK; Buller RM; Bellone CJ; Chen JJ; Cohen GH; Eisenberg RJ; Belshe RB; Stanley SL; Frey SE
    J Infect Dis; 2007 Jul; 196(2):220-9. PubMed ID: 17570109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodomination during peripheral vaccinia virus infection.
    Lin LC; Flesch IE; Tscharke DC
    PLoS Pathog; 2013; 9(4):e1003329. PubMed ID: 23633956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T cells provide intermolecular help to generate robust antibody responses in vaccinia virus-vaccinated humans.
    Yin L; Calvo-Calle JM; Cruz J; Newman FK; Frey SE; Ennis FA; Stern LJ
    J Immunol; 2013 Jun; 190(12):6023-33. PubMed ID: 23667112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques.
    Walsh SR; Gillis J; Peters B; Mothé BR; Sidney J; Sette A; Johnson RP
    Vaccine; 2009 Aug; 27(36):4990-5000. PubMed ID: 19531389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults.
    Zhou W; Sharma M; Martinez J; Srivastava T; Diamond DJ; Knowles W; Lacey SF
    Viral Immunol; 2007 Sep; 20(3):379-88. PubMed ID: 17931108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses.
    Moutaftsi M; Bui HH; Peters B; Sidney J; Salek-Ardakani S; Oseroff C; Pasquetto V; Crotty S; Croft M; Lefkowitz EJ; Grey H; Sette A
    J Immunol; 2007 Jun; 178(11):6814-20. PubMed ID: 17513729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates.
    Hooper JW; Custer DM; Thompson E
    Virology; 2003 Feb; 306(1):181-95. PubMed ID: 12620810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable polyfunctionality of ectromelia virus- and vaccinia virus-specific murine T cells despite markedly different in vivo replication and pathogenicity.
    Hersperger AR; Siciliano NA; Eisenlohr LC
    J Virol; 2012 Jul; 86(13):7298-309. PubMed ID: 22532670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.
    Hooper JW; Custer DM; Schmaljohn CS; Schmaljohn AL
    Virology; 2000 Jan; 266(2):329-39. PubMed ID: 10639319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.